News Conference News TCT 2017 Experts Debate: Should Cerebral Protection Be Used for All TAVRs? Todd Neale November 09, 2017
News Conference News TCT 2017 A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients Todd Neale November 08, 2017
News Conference News TCT 2017 Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used Todd Neale November 02, 2017
News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Four Shelley Wood November 02, 2017
Presentation TCT 2017 PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation Presenter: Saibal Kar November 02, 2017
Presentation TCT 2017 Case #2 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni November 01, 2017
Presentation TCT 2017 Case #2 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni November 01, 2017
Presentation TCT 2017 Case #1 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora November 01, 2017
Presentation TCT 2017 Case #1 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora November 01, 2017
Presentation TCT 2017 Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Presenter: Samir R. Kapadia, Ioanna Kosmidou November 01, 2017
Presentation TCT 2017 Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Presenter: Samir R. Kapadia, David J. Moliterno November 01, 2017
Presentation TCT 2017 Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Presenter: Samir R. Kapadia, Sameer Gafoor November 01, 2017
Presentation TCT 2017 PIONEER AF: Topline Findings and Practice Implications Presenter: Robert A. Harrington, Evan A. Stein, C. Michael Gibson November 01, 2017
Presentation TCT 2017 Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset Presenter: Samir R. Kapadia, Brian K. Whisenant November 01, 2017
Presentation TCT 2017 Rationale and Potential Role for LAA Closure in the PCI and ACS Patient Presenter: Samir R. Kapadia, Ashish Pershad November 01, 2017
Presentation TCT 2017 The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Presenter: Deepak L. Bhatt, C. Michael Gibson, Pascal Vranckx November 01, 2017
Presentation TCT 2017 Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial) Presenter: Samir R. Kapadia November 01, 2017
Presentation TCT 2017 The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI - Design, Rationale, and Status Presenter: Deepak L. Bhatt, C. Michael Gibson, Renato D. Lopes November 01, 2017
Presentation TCT 2017 The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice Presenter: Deepak L. Bhatt, C. Michael Gibson November 01, 2017
Presentation TCT 2017 The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation - Are the Results Enough to Change Practice? Presenter: Deepak L. Bhatt, C. Michael Gibson November 01, 2017